Sol-Gel Technologies Ltd

SLGL NASDAQ Healthcare & Biotech Israel IL0011417206
71.22 $
3.10 %

Sol-Gel is a pharmaceutical company specializing in dermatological drug formulations.

Performance & Momentum

6 Months 94.67 %
1 Year 943.24 %
3 Years 121.41 %
5 Years 27.12 %

Strategic Analysis

Sol-Gel specializes in innovative dermatological formulations for the pharmaceutical sector, leveraging sharp expertise in niche topical treatments. Its Israeli positioning allows it to benefit from a dynamic biotechnology ecosystem while targeting a global market that is in high demand for differentiated dermatological solutions.

Strengths
  • Advanced technical expertise in dermatological formulation
  • Strong growth momentum in recent periods
  • Positioning in a specialized pharmaceutical segment with innovation potential
Weaknesses
  • Marked volatility with mixed performance over the medium to long term
  • Lack of broad geographical or therapeutic diversification
Momentum

The exceptionally high momentum reflects a resurgence of interest supported by favorable market dynamics and possibly recent technical or commercial advancements. This trend suggests a short to medium-term opportunity but requires caution in the context of significant past fluctuations.

Similar stocks to Sol-Gel Technologies Ltd

Anantys Community

Be the first to share your analysis on Sol-Gel Technologies Ltd.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases